Immunotherapy for advanced and recurrent malignant pleural mesothelioma.

Humans Pleural Neoplasms / therapy Mesothelioma, Malignant / therapy Immunotherapy / methods Immune Checkpoint Inhibitors / therapeutic use Neoplasm Recurrence, Local Randomized Controlled Trials as Topic Mesothelioma / therapy Lung Neoplasms / therapy Salvage Therapy / methods

Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
18 Sep 2024
Historique:
medline: 18 9 2024
pubmed: 18 9 2024
entrez: 18 9 2024
Statut: epublish

Résumé

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of immune checkpoint inhibitors (single-agent or combination therapy) in people with advanced malignant pleural mesothelioma in a first-line or salvage setting.

Identifiants

DOI: 10.1002/14651858.CD014720 PMID: 39291744
pubmed: 39291744
doi: 10.1002/14651858.CD014720
doi:

Substances chimiques

Immune Checkpoint Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD014720

Informations de copyright

Copyright © 2024 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Auteurs

Anna Karen Haugaard (AK)

Department of Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.

Rita Saude Conde (R)

Digestive Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Brussels, Belgium.

Ana Rita J Maria (AR)

Comprehensive Health Research Centre, Nova Medical School | Faculdade de Ciências Médicas da Universidade NOVA de Lisboa, Lisbon, Portugal.

Abhijna Vithal Yergolkar (A)

Naperville, Illinois, USA.

Karsten Juhl Jørgensen (KJ)

Cochrane Denmark and Centre for Evidence Based Medicine Odense, University of Southern Denmark, Odense, Denmark.

Bruno Heleno (B)

Comprehensive Health Research Centre, Nova Medical School | Faculdade de Ciências Médicas da Universidade NOVA de Lisboa, Lisbon, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs de la plèvre › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs de la plèvre › Mésothéliome malin › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Antinéoplasiques immunologiques › Inhibiteurs de points de contrôle immunitaires › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Récidive tumorale locale › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › Essais cliniques contrôlés comme sujet › Essais contrôlés randomisés comme sujet › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs mésotheliales › Mésothéliome › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Immunotherapy for advanced and recurrent...
questionsmedicales.fr › Thérapeutique › Thérapie de rattrapage › Immunotherapy for advanced and recurrent...